|
|
|
|
|
|
| Changes of Tumor Cell Components Induced by Pain-Related Neuropeptides SP Investigated by Synchrotron Radiation Infrared Microscopic Imaging Technology |
| YANG Chao1, ZHU Zhen2, LI Jing4, SUN Yun-heng5, OUYANG Xue-yan1, WANG Jia-wei2, HUANG Qian1, DING Gang3, WANG Yao-sheng1*, JIANG Feng1* |
1. Translational Institute for Cancer Pain, Xinhua Hospital Chongming Branch, Shanghai 202150, China
2. School of Life Sciences and Medicine, Shanghai University, Shanghai 202436, China
3. Department of Oncology, Shanghai International Medical Center, Shanghai 201318, China
4. Henan People’s Hospital, Zhengzhou 450003, China
5. Shanghai Cancer Institute, Renji Hospital, Shanghai 200032, China |
|
|
|
|
Abstract Pain is one of the most common symptoms in cancer patients, but for a long time, the control of pain symptoms in clinical cancer treatment still cannot get enough attention. The mechanism of pain promoting tumor has not been fully understood. Substance P (SP), as a neuropeptide mediating pain, is highly expressed in serum of patients with cancer pain. In this study, the SP stimulated tumor cells were collected and analyzed by synchrotron radiation microscopic infrared spectroscopy imaging, in order to reveal the possible mechanism of pain promoting tumor. Results show that in the breast cancer cell lines MDA-MB-231, MCF-7, and lung cancer cell lines A549, SPCA, the absorption peak of amide I near 1 655 cm-1 which reflect the secondary structure of the protein, showed blue shift. Suggesting that SP stimulate tumor cells may cause tumor cell protein secondary structure change. In MDA-MB-231 and A549, the absorption peaks of amide I and amide II which located in 1 500~1 600 and 1 600~1 700 cm-1 also declined significantly, show that in the two cell lines, the protein expression of tumor cells is significantly lower. In A549 cell line, the symmetric stretch vibration peaks of phosphodiester group in 1 070~1 090 and 1 230~1 250 cm-1 show blue shift, indicating that SP stimulated A549 cell lines also affected the nucleic acid structure of this cell line, suggesting that SP may cause the damage of tumor suppressor genes and the activation of oncogenes. Synchrotron radiation micro-infrared imaging analysis revealed that persistent pain symptoms affect the biological activity of tumor cells through the release of neurotransmitters, possibly by changing the structure of proteins and nucleic acids in tumor cells. The results of spectroscopy showed that the presence of pain and other adverse symptoms and the release of pain-related substances may affect the protein structure and expression in tumor cells and the change of nucleic acid in tumor cells, which might have adverse effects on the treatment of tumors. In clinical tumor treatment, attention should be paid not only to killing tumor cells but also to symptomatic control of symptoms.
|
|
Received: 2019-10-18
Accepted: 2020-02-09
|
|
|
|
Corresponding Authors:
WANG Yao-sheng, JIANG Feng
E-mail: jf365321@163.com；wangyaosheng@xinhuamed.com.cn
|
|
[1] Yang L, Zheng R, Wang N, et al. Chin. J. Cancer Res., 2018, 30(3): 291.
[2] Masel E K, Schur S, Nemecek R, et al. Ann. Palliat Med., 2017, 6(1): 6.
[3] Steinhoff M S, von Mentzer B, Geppetti P, et al. Physiol. Rev., 2014, 94(1): 265.
[4] Suvas S. J. Immunol., 2017, 199(5): 1543.
[5] Sun T, Jiang X, Wang Q, et al. ACS Appl. Mater Interfaces, 2017, 9(40): 34603.
[6] Lupu M, Caruntu A, Caruntu C, et al. Oncol. Rep., 2017, 38(3): 1327.
[7] Chen X Y, Ru G Q, Ma Y Y, et al. OncoTargets Ther., 2016, 9: 3595.
[8] Robinson P, Kasembeli M, Bharadwaj U, et al. Biomed. Res. Int., 2016, 2016: 1959270.
[9] Bunaciu A A, Hoang V D, Aboul-Enein H Y. Crit. Rev. Anal. Chem., 2015, 45(2): 156.
[10] Raczkowska M K, Koziol P, Urbaniak-Wasik S, et al. Anal. Chim. Acta, 2019, 1085: 39.
[11] Nallala J, Lloyd G R, Shepherd N, et al. Analyst, 2016, 141(2): 630.
[12] Bunaciu A A, Udristioiu G E, Ruta L L, et al. Saudi. Pharm. J., 2009, 17(4): 303.
[13] Chwiej J, Dulinska J, Janeczko K, et al. J. Chem. Neuroanat., 2010, 40(2): 140.
[14] Surowka A D, Pilling M, Henderson A, et al. Analyst, 2016, 142(1): 156
[15] Grzelak M M, Wrobel P M, Lankosz M, et al. Spectrochim Acta A: Mol. Biomol. Spectrosc.，2018, 203: 48. |
| [1] |
LU Wen-jing, FANG Ya-ping, LIN Tai-feng, WANG Hui-qin, ZHENG Da-wei, ZHANG Ping*. Rapid Identification of the Raman Phenotypes of Breast Cancer Cell
Derived Exosomes and the Relationship With Maternal Cells[J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2023, 43(12): 3840-3846. |
| [2] |
CHEN Wen-jing, XU Nuo, JIAO Zhao-hang, YOU Jia-hua, WANG He, QI Dong-li, FENG Yu*. Study on the Diagnosis of Breast Cancer by Fluorescence Spectrometry Based on Machine Learning[J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2023, 43(08): 2407-2412. |
| [3] |
ZHANG Bao-ping1, NING Tian1, ZHANG Fu-rong1, CHEN Yi-shen1, ZHANG Zhan-qin2, WANG Shuang1*. Study on Raman Spectral Characteristics of Breast Cancer Based on
Multivariable Spectral Data Analysis Methods[J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2023, 43(02): 426-434. |
| [4] |
GAO Fei1, XIONG Yang2 , ZHANG Ming1, ZHU Shao-ling3 . Investigations on NIR-SERS Spectra of Oxyhemoglobin for Lung Cancer Based on NIR-SERS Substrate [J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2017, 37(02): 441-445. |
| [5] |
HU Hai-jian1,2, ZU Chao1, GUO Lin2,3, HU Qing-nan4, WANG Jian-sheng1*, XU Yi-zhuang2*, WU Jin-guang2 . Application of FTIR Spectrometry to Monitoring Chemosensitivity of Breast Cancer Cell Line Using 5-FU[J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2013, 33(11): 2935-2939. |
| [6] |
GUO Li1, ZHANG Yi1*, Lü Jin-yan2, GAO Wen-bin2, WU Shi-fa1, WANG Ruo-yu2 . Multivariate Statistical Analysis of Serum from Breast Cancer Patients Using Surface Enhanced Raman Spectrum[J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2013, 33(06): 1553-1556. |
| [7] |
LI Xiao-zhou1, 2, YANG Tian-yue1, DING Jian-hua2 . Surface Enhanced Raman Spectroscopy (SERS) of Saliva for the Diagnosis of Lung Cancer [J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2012, 32(02): 391-393. |
| [8] |
ZHANG Lin-lin1, MA Qian-li2, HUANG Yun-chao2, WU Guo-ping3, WEI Fu-sheng3* . Determination of Thirty Three Elements in Lung Cancer Tissues of Patients with Lung Cancer by Microwave Digestion-ICP-MS[J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2009, 29(12): 3388-3391. |
| [9] |
XU Hao1, CHEN Chuang2, LIU Chun-mei1, PENG Jun1, LI Yan2, ZHANG Zhi-ling1, TANG Hong-wu1* . The Distribution Analysis of the Biomarkers on Breast Cancer Tissues by Hadamard Transform Spectral Microscopic Imaging [J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2009, 29(12): 3216-3219. |
| [10] |
WU Yong-jun,HAO Yan-hong,WU Wei-chao,WU Yi-ming* . Value of Auto-Fluorescence Spectrum Combined with Tumor Markers in Diagnosis of Lung Cancer [J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2009, 29(10): 2787-2791. |
| [11] |
GAO Tian-xin1,3,FAN Xiao-fei1,XUAN Li-xue2,ZHANG Bao-ning2, LI Xia1,BAI Jing1*. The Clinical Detection of Breast Cancer by Spectrum Method[J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2008, 28(11): 2531-2535. |
| [12] |
LIU Yan-nan1,3,ZOU Zu-quan2,3,LIU Yan-qing4,XU Xiao-xuan1,3,YU Gang1,3,ZHANG Cun-zhou1,3. Surface-Enhanced Raman Spectra of Natural Tissue and Cancerous Tissue of Lung[J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2007, 27(10): 2045-2048. |
| [13] |
XIONG Yi-jie1, OUYANG Li1, 2, LIU Ya-qiong1, 2, XIE Qing1, 2, LIU Hu-sheng1, WANG Jing-yu1, 2* . Determination of Fifty-Five Elements in Lung Carcinomatous Tissues and Their Pericarcinomatous Tissues by Atomic Spectrometry [J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2006, 26(11): 2120-2124. |
| [14] |
LING Xiao-feng1, XU Zhi1, XU Yi-zhuang2*, LI Qing-bo2, ZHOU Su1, ZHANG Li2, ZHAO Hong-mei1, HOU Chun-sheng1, WANG Li-xin1, HOU Kuan-yong1, ZHOU Xiao-si1, WU Jin-guang2 . FTIR Spectroscopic Explorations of Clinical Practice of Breast Cancer [J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2005, 25(02): 198-200. |
| [15] |
YAN Xun-ling1，DONG Rui-xin1, 2，WANG Qiu-guo1，CHEN Shuang-feng3，ZHANG Zong-wang4，ZHANG Xue-jun4，ZHANG Lei4. Raman Spectra of Cell from Breast Cancer Patients [J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2005, 25(01): 58-61. |
|
|
|
|
